Less intense therapy for HPV-positive throat cancer
Part of Cancer clinical trials.
This trial tests a less intense treatment plan for HPV-positive throat cancer that is caught early or moderately advanced. The goal is to keep the cancer from coming back while reducing side effects from standard therapy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have HPV-positive throat cancer (confirmed by a special test called p16).
- Your cancer must be at an early or intermediate stage, such as T1-T3, N0-N2b (or T1-T3, N0-N1 on the newer system).
- Your treatment plan must include surgery (transoral removal of the tumor) and a neck dissection.
- You must be 18 years or older and considered healthy enough for surgery and follow-up treatment.
- You cannot have had radiation to the head or neck before, and you cannot be pregnant or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether giving lower doses of radiation to certain parts of the throat can be just as effective as standard doses, while reducing side effects. It is for people with HPV-positive throat cancer, which tends to respond well to treatment.
This study tries to see if less intense radiation can still work well for certain throat cancers linked to HPV. It is looking for people with early stage HPV-positive oropharynx cancer who may benefit from a lighter treatment plan.
This trial tests whether using a de-escalated (lower/intensity-reduced) radiation approach can treat HPV-positive oropharyngeal squamous cell carcinoma. It may help reduce side effects while still keeping the cancer under control.
This trial studies a lower-intensity (less aggressive) course of radiation therapy after curative surgery for HPV-related tonsil or base-of-tongue cancer. The goal is to see if patients can still be treated successfully while reducing side effects from radiation.
This trial tests whether a lower dose of radiation to the neck is safe and effective for people with HPV-related oropharyngeal cancer. It may reduce side effects while still treating the cancer.
This trial tests whether giving less radiation after surgery is safe and effective for people with early-stage HPV-related throat cancer. It aims to reduce side effects while still controlling the cancer.
Hear when a new Oropharyngeal Squamous Cell Carcinoma (SCC) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.